AIDS Vaccine Clearinghouse
HOME  •  SEARCH  •  CONTACT US  •  JOIN THE AVAC MAILING LIST  •  SUPPORT AVAC    

About AVAC
About AIDS Vaccines
AVAC's Top Picks
Take Action
AIDS Vaccine Handbook
AVAC Reports

Timelines:
- Vaccines:
13 Years & Counting

- HIV Prevention Research: A Comprehensive Timeline
AVAC Publications
In the News

What Research is
Happening and Where
Good Participatory Practice (GPP)
Regulatory Advocacy
AVAC Fund
AIDS Vaccine Clearinghouse
Links
Opportunities at AVAC


Advocacy

Good Participatory Practice (GPP)


About GPP

logo Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials is a document that was drafted by a multidisciplinary international group including community advocates, research staff, and NGO representatives. The group was convened by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and AVAC. A draft version of the guidelines was then further refined through broad consultation involving a wide range of stakeholders.

 


To download a copy of the full text of this document in multiple languages, see below.

 

This is a living document. It will only be useful if it is put into practice, evaluated, edited, updated and made part of the ongoing dialogue around prevention research worldwide.

 

To that end, in February, AVAC announced a call for proposals for AVAC-supported projects to support Community Consultations on Good Participatory Practice Guidelines (CC-GPP). In addition to funding, AVAC is committed to providing technical support and related materials (including a user-friendly GPP summary document) to interested groups. In April, the first round of GPP partners were announced.

 

**********


AVAC’s Community Consultations on the GPP Guidelines

 

GPP_map

 

 

Through consultative meetings, interviews, focus group discussions, and other activities, AVAC’s partners will engage with stakeholder groups to gain critical feedback on the GPP guidelines.

 

AVAC’s GPP Partners


▪  Asociacion Civil Selva Amazonica
▪  Centre for the AIDS Programme of Research in South Africa (CAPRISA)
▪  Community Education Group, Inc. (CEG)
▪  Grupo de Incentivo a Vida (GIV) with Unidade de Pesquisa de Vacina Anti-HIV (UPSP)
▪  Kenya AIDS NGOs Consortium (KANCO) with Kenya AIDS Vaccine Initiative (KAVI) and University of Nairobi Centre for HIV Prevention & Research (UoN-CHIVPR)
▪  Makerere University-Walter Reed Project (MUWRP)
▪  National AIDS Education & Services for Minorities, Inc. (NAESM)New HIV Vaccine and Microbicide Advocacy Society (NHVMAG)
▪  Perinatal HIV Research Unit (PHRU)
▪  Planeta Salud
▪  Sex Workers Project at the Urban Justice Center
▪  Thai AIDS Treatment Action Group (TTAG)


-------------------------------------------------------------------------------------------------------------------------
GPP guidelines and related Documents

 

cover
Good participatory practice guidelines for biomedical HIV prevention trials

English
Español

Français
Português

中文

الْعَرَبيّة

 

 



GPP Facilitator's Guide

To help make the full GPP guidelines easier to understand and more accessible to a wider range of stakeholders, AVAC has developed a Facilitator's Guide for community use. The Facilitator's Guide is a companion to the full GPP guidelines and provides a summary of the guidelines, discussion tools and case studies.

English - A4 size formatting
English - 8.5" x 11" size formatting

(Additional languages coming soon)

 

Ethical Considerations in Biomedical HIV Prevention Trials

English
Español

Français
Português

中文

الْعَرَبيّة

русский

 

 

 

This website Copyright 2006 AIDS Vaccine Advocacy Coalition

Site Design: Canfield Design Studios, Inc.





HOME  •  SEARCH  •  CONTACT US  •  JOIN THE AVAC MAILING LIST  •  SUPPORT AVAC